Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.86% | -5.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.86% | -5.16% | |||
| Cost of Revenue | 7.41% | 0.34% | |||
| Gross Profit | 5.27% | -7.09% | |||
| SG&A Expenses | 2.11% | -3.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.21% | -0.22% | |||
| Operating Income | -1.65% | -8.54% | |||
| Income Before Tax | -4.77% | -8.95% | |||
| Income Tax Expenses | 31.11% | 255.26% | |||
| Earnings from Continuing Operations | -5.02% | -9.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.02% | -9.66% | |||
| EBIT | -1.65% | -8.54% | |||
| EBITDA | -1.54% | -8.85% | |||
| EPS Basic | -3.79% | -8.62% | |||
| Normalized Basic EPS | -3.53% | -7.96% | |||
| EPS Diluted | -3.79% | -8.62% | |||
| Normalized Diluted EPS | -3.53% | -7.96% | |||
| Average Basic Shares Outstanding | 1.19% | 0.94% | |||
| Average Diluted Shares Outstanding | 1.19% | 0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||